2023 Posters

Stephanie Mou

Advanced RNA Vaccine Technologies (ARV Tech)

Design and Preclinical Evaluation of a Universal SARS-CoV-2 mRNA Vaccine

Pawan Dulal

aVaxziPen Limited

Needle-free, injectable solid dose vaccine delivery generates equivalent immune response with different antigens and animal models

Karen Berliner

BioIntegrity, LLC

Establishing a High-Quality Biospecimen Resource in a Pandemic Setting: Challenges and Lessons Learned

Olivier Loget

CapEval Pharma

Non-clinical safety assessment of vaccines

Mafalda Cacciottolo

Capricor Therapeutics

Multivalent Exosome based vaccine: a “cocktail” approach to epidemic viruses’ challenges.

Mafalda Cacciottolo

Capricor Therapeutics

Exosome based multivalent vaccine: achieving potent immunization, broaden reactivity and T cell response with nanograms of proteins without any adjuvant.

Michael Egan

CastleVax

CastleVax’s Newcastle Disease Virus vectored-vaccine platform is ideally suited to address current and future viral threats.

Huiju Lim

CHA Vaccine Institute, Co., Ltd.

Novel TLR2/3 Ligand Based Vaccine Adjuvant Systems for Infectious Diseases and Cancer

Zhilin Chen

Codiak Biosciences

Development of an Exosome-based Pan Beta-Coronavirus Vaccine

Andrew Andraski

Colorado State University

Development of a Scalable, High Throughput, Low Energy Consuming, Rapid Vaccine Production Device

Lauren Speciner

Combined Therapeutics

MOPCTx: The next generation of mRNA-based vaccines to prevent infectious diseases with improved biodistribution and safety profiles

Julie LaValley

Dyadic International, Inc.

DEVELOPMENT OF THE FILAMENTOUS FUNGUS Thermothelomyces heterothallica, C1, INTO A NEXT-GENERATION PRODUCTION PLATFORM FOR HUMAN AND ANIMAL VACCINES

Natasha Chaudhary

Elarex Inc

Pullulan and Trehalose Room Temperature Stabilization of VSV Vectored Therapeutics

Vanja Komlenovic

Emergent BioSolutions Inc.

Evaluation of the Immune Response to ACAM2000® Vaccine in Previously Vaccinated Individuals

Jemin Han

EuBiologics Co., Ltd.

Development of subunit vaccine platform based on nanoparticles using novel adjuvant and antigen display technology

Sunjong Kwon

Eyegene Inc.

Novel freeze-dried, thermostable, low-cost COVID-19 mRNA vaccines targeting WT (614Gm strain) and the Omicron BA.1 variant

Pil-Gu Park

Gachon University

Development of platform technology using plants for rapid production of subunit vaccine against nipah virus

Nicolas Gaudenzio

Genoskin

High-dimensional profiling of immune response to vaccines using bio-stabilized and injectable natural human skin.

Richard Guy

ImmunAdd Inc.

Next Generation Saponin-Based Vaccine Adjuvants

Chiara Nicolò

InSilicoTrials Technologies SpA

InSilicoVACCINE: a suite of computational models for vaccine design and trial simulation

Mark Cashin

Integrum Scientific

Longitudinal blood specimen collection from survivors of emerging infectious diseases

Anas Tomeh

Labcorp Drug Development

Second Generation mRNA Vaccines: Formulation development of mRNA-lipid nanoparticles with TLR9 agonist CpG oligonucleotide adjuvant

David Hesley

Merck & Co.

Revival of a legacy DNA vaccine E. coli plasmid fermentation process utilizing single-use technology to support a modern mRNA vaccine program

Brunah Otieno

Meso Scale Diagnostics, LLC

Validation of Novel Multiplexed Serology Assays for Detection of IgG Antibodies against SARS-COV-2 Key Variants

Carolina Braghini Stephenson

MilliporeSigma

Media development strategies for vaccine, oncolytic virus therapy and gene therapy applications

Kamran Anwar

MilliporeSigma

Quality Control Testing of mRNA Vaccines To Ensure Integrity of Critical Attributes

Maggie Luce

MilliporeSigma (BioReliance)

Adventitious Agent Testing using Next Generation Sequencing: Incorporating a Benzonase  Pre-Treatment to Lower Host Sequence Representation and Improve the Limit of Detection

Rebecca Bova

MilliporeSigma (BioReliance)

Validation of a Next Generation Sequencing (NGS) for Adventitious Virus Detection in Vaccine Other Biological Products

Catherine Panozzo

Moderna, Inc.

Near real-time surveillance of RSV to support clinical trial enrollment strategies in ConquerRSV

Alexander Seifalian

NanoRegMed Ltf

A new intranasal vaccine formulation for protection against SARS-CoV-2 virus infection

Romane Beneston

NeoBioSys

Bacterial bioprocess development and intensification

Edward Kwee

NIST

Validation of live-cell imaging and flow cytometry methods for quantifying serum neutralization in a  SARS-CoV-2 pseudovirus neutralization assay

Christopher Graves

Ogilvy

TOWARDS PRECISION HEALTH ENGAGEMENT: A BEHAVIORAL SCIENCE APPROACH TO DECODING VACCINE HESITANCY IN INDIVIDUALS AT SCALE IN ORDER TO EFFECTIVELY MATCH MESSAGING

Nicolas Legrand

Oncodesign Services

Preclinical evaluation of a chimpanzee adenovirus vector expressing a pre-fusion Spike (BV-AdCoV-1) SARS-CoV-2 vaccine candidates in golden Syrian hamsters

Simon Bennett

One Health Ventures

Epsilon toxin, Multiple Sclerosis and Vaccine Candidate

Katherine Schneider

Pfizer

Validation of a Molecular Diagnostic Approach for Detecting Borrelia burgdorferi sensu lato spp. in Tissue and Other Biological Samples

Vanessa Borowicz

Precision NanoSystems

Accelerated development of self-amplifying RNA (saRNA) vaccines using scalable NxGenTM Microfluidics

Jeonghun Kim

Progeneer Inc.

mRNA Cancer Vaccine Adjuvanted with Timely Activating Cholesterol-linked TLR7/8 Agonist Showed Protective Immunity in Melanoma Mouse Model

Jeonghun Kim

Progeneer Inc.

Neoantigen Cancer Vaccine Adjuvanted with Liposomal Cholesterol-linked TLR7/8 Agonist Showed Protective Immunity in Melanoma Mouse Model

Jeonghun Kim

Progeneer Inc.

Nucleoprotein Antigen Adjuvanted with Liposomal Cholesterol-linked TLR7/8 Agonist Showed Protective Immunity in Influenza Mouse Model

Maxime Lestra

RD-BIOTECH

The central role of pDNA in new therapies development

Hyewon Youn

Seoul National Univeirsity Hospital

Molecular imaging based evaluation of mRNA vaccine candidates

Marie-Eve Koziol

SEPPIC

MONTANIDE™ ISA 51 VG & MONTANIDE™ ISA 720 VG: open access adjuvants dedicated to therapeutic vaccines

Katrin Van Leuven

SGS

Determining the stability of a new RSV strain to be used in Controlled Human Infection Model studies

Candice Chan

Singapore General Hospital, Duke-NUS Medical School

Factors affecting immune response to the herpes zoster vaccine in the elderly population

Izabela Ragan

Solaris Vaccines

SolaVAX: A Novel Photochemical Inactivation Method of the Rapid Production of Inactivated Vaccines

Tarra Shingler

StudyKIK

Vax’d: An App for Engaging Patient Experiences and Enhanced Symptom Tracking and Follow-Up

Anass Jawhari

Thermo Fisher Scientific, Materials and Structural Analysis Division

Leveraging Cryo-Electron Microscopy for Innovative Vaccine Development

Gillot Constant

UNamur

Dynamics of Neutralizing Antibody Responses Following Natural SARS-CoV-2 Infection and Correlation with Commercial Serologic Tests

Gillot Constant

UNamur

Vaccine-induced binding and neutralizing antibodies against Omicron 6 months after a homologous BNT162b2 booster

Victor Bronshtein

Universal Stabilization Technologies Inc.

Thermostable Vaccines Inactivated via Electron Beam and Ultraviolet Radiation

Aaron Gingerich

University of Georgia

A pan-Pneumovirus vaccine based on immunodominant epitopes of the fusion protein

Erika Petro-Turnquist

University of Nebraska-Lincoln

An adenoviral-vectored Epigrah vaccine induces durable immune responses against H3 Influenza A Virus in swine

Stéphanie Meyer

Valneva GmbH, Austria

Progress of Clinical Development of a Live-Attenuated Single Shot Chikungunya Vaccine Candidate

Matt Vukovich

Vanderbilt University

Isolation and Characterization of Broad Glycan-Reactive Antibodies that Target Multiple Viral Antigens

Elodie Burlet

VaxForm

Oral DTaP Vaccination Induces Mucosal and Systemic Immunity in Mice

Ilya Goldberg

ViQi Inc.

A Cloud-based Rapid and Scalable Infectivity Assay for Vaccine and Antiviral Screening

Andrea Vervoort

Virica Biotech

Virus Production Enhancement Using Small Molecule VSEs TM

Julia Sakamoto

Vernal Biosciences

Potent anti-SARS-CoV-2 Spike Protein Immune Responses with LNP-mRNA in Mice

Charlotte Mignon

Bioaster

Deep longitudinal multi-omics analysis of Bordetella pertussis cultivated in bioreactors highlights medium starvations and transitory metabolisms

Sabine Hauck

Leukocare AG

Implementation of analytical Methods for mRNA-LNPs addressing stability indicating Critical Quality Attributes (CQAs) and their application

Luciana Cezar De Cerqueira Leite

Instituto Butantan

Neonate mice immunized with a recombinant BCG-PspA-PdT prime: boost scheme displays a robust immune response and protection against lethal pneumococcal challenge